• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国 COVID-19 相关的潜在医疗保健成本和资源利用

The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States.

机构信息

Sarah M. Bartsch is a project director at Public Health Informatics, Computational, and Operations Research (PHICOR), Graduate School of Public Health and Health Policy, City University of New York, in New York City.

Marie C. Ferguson is a project director at PHICOR, Graduate School of Public Health and Health Policy, City University of New York.

出版信息

Health Aff (Millwood). 2020 Jun;39(6):927-935. doi: 10.1377/hlthaff.2020.00426. Epub 2020 Apr 23.

DOI:10.1377/hlthaff.2020.00426
PMID:32324428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11027994/
Abstract

With the coronavirus disease 2019 (COVID-19) pandemic, one of the major concerns is the direct medical cost and resource use burden imposed on the US health care system. We developed a Monte Carlo simulation model that represented the US population and what could happen to each person who got infected. We estimated resource use and direct medical costs per symptomatic infection and at the national level, with various "attack rates" (infection rates), to understand the potential economic benefits of reducing the burden of the disease. A single symptomatic COVID-19 case could incur a median direct medical cost of $3,045 during the course of the infection alone. If 80 percent of the US population were to get infected, the result could be a median of 44.6 million hospitalizations, 10.7 million intensive care unit (ICU) admissions, 6.5 million patients requiring a ventilator, 249.5 million hospital bed days, and $654.0 billion in direct medical costs over the course of the pandemic. If 20 percent of the US population were to get infected, there could be a median of 11.2 million hospitalizations, 2.7 million ICU admissions, 1.6 million patients requiring a ventilator, 62.3 million hospital bed days, and $163.4 billion in direct medical costs over the course of the pandemic.

摘要

随着 2019 年冠状病毒病(COVID-19)大流行,人们主要关注的是该病给美国医疗体系带来的直接医疗费用和资源使用负担。我们开发了一个蒙特卡罗模拟模型,代表了美国人口以及每个感染者可能发生的情况。我们估计了每例有症状感染的资源使用和直接医疗费用,并按全国水平进行了估计,同时考虑了各种“发病率”(感染率),以了解减轻疾病负担的潜在经济效益。在感染过程中,单个有症状的 COVID-19 病例的直接医疗费用中位数可能为 3045 美元。如果 80%的美国人口被感染,可能导致中位数 4460 万例住院治疗、1070 万例重症监护病房(ICU)入院、650 万例需要呼吸机的患者、24.95 亿个住院床位日,以及在大流行期间直接医疗费用 6540 亿美元。如果 20%的美国人口被感染,可能导致中位数 1120 万例住院治疗、270 万例 ICU 入院、160 万例需要呼吸机的患者、6230 万个住院床位日,以及在大流行期间直接医疗费用 1634 亿美元。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/016f/11027994/15d4ebd43d64/nihms-1981236-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/016f/11027994/72fdf4284b10/nihms-1981236-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/016f/11027994/15d4ebd43d64/nihms-1981236-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/016f/11027994/72fdf4284b10/nihms-1981236-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/016f/11027994/15d4ebd43d64/nihms-1981236-f0002.jpg

相似文献

1
The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States.美国 COVID-19 相关的潜在医疗保健成本和资源利用
Health Aff (Millwood). 2020 Jun;39(6):927-935. doi: 10.1377/hlthaff.2020.00426. Epub 2020 Apr 23.
2
Economic Impacts of the COVID-19 Crisis: An Orthopaedic Perspective.2019冠状病毒病危机的经济影响:骨科视角
J Bone Joint Surg Am. 2020 Jun 3;102(11):937-941. doi: 10.2106/JBJS.20.00557.
3
Medical costs of keeping the US economy open during COVID-19.在 COVID-19 期间保持美国经济开放的医疗费用。
Sci Rep. 2020 Oct 28;10(1):18422. doi: 10.1038/s41598-020-75280-6.
4
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.卡维地洛对心力衰竭住院率的影响:发病率、资源利用及成本。美国卡维地洛心力衰竭研究组。
J Am Coll Cardiol. 2001 May;37(6):1692-9. doi: 10.1016/s0735-1097(01)01190-1.
5
The COVID-19 Pandemic and the $16 Trillion Virus.新冠疫情与“16万亿美元病毒”
JAMA. 2020 Oct 20;324(15):1495-1496. doi: 10.1001/jama.2020.19759.
6
Spatiotemporal analysis of medical resource deficiencies in the U.S. under COVID-19 pandemic.新冠疫情下美国医疗资源短缺的时空分析。
PLoS One. 2020 Oct 14;15(10):e0240348. doi: 10.1371/journal.pone.0240348. eCollection 2020.
7
Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis.中国山东 2019 年冠状病毒病治疗:成本与可负担性分析。
Infect Dis Poverty. 2020 Jun 29;9(1):78. doi: 10.1186/s40249-020-00689-0.
8
Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.严重脓毒症的经济学方面:重症监护病房成本、疾病成本及治疗成本效益综述
Pharmacoeconomics. 2004;22(12):793-813. doi: 10.2165/00019053-200422120-00003.
9
Covid-19 pandemic and Nepal.新冠疫情与尼泊尔
Med Leg J. 2020 Jul;88(2):102-103. doi: 10.1177/0025817220923690. Epub 2020 May 19.
10
COVID-19 and Underinvestment in the Health of the US Population.新冠疫情与美国对民众健康投入不足
Milbank Q. 2020 Jun;98(2):239-249. doi: 10.1111/1468-0009.12462. Epub 2020 May 13.

引用本文的文献

1
Optimal pandemic control strategies and cost-effectiveness of COVID-19 non-pharmaceutical interventions in the United States.美国新冠疫情的最佳防控策略及非药物干预措施的成本效益
BMC Glob Public Health. 2025 Sep 12;3(1):76. doi: 10.1186/s44263-025-00189-z.
2
The Global COVID-19 Pandemic Experience: Innovation Through Environmental Assessment and Seropositivity Surveillance.全球新冠疫情经历:通过环境评估和血清阳性监测实现创新
Int J Environ Res Public Health. 2025 Jul 18;22(7):1145. doi: 10.3390/ijerph22071145.
3
Granular Insights:A Wastewater-Based Machine Learning Approach for Localized COVID-19 Hospitalization Forecasting.

本文引用的文献

1
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.2020 年 2 月 12 日至 3 月 16 日,美国 2019 冠状病毒病(COVID-19)患者的严重结局。
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.
2
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.估算 2020 年日本横滨钻石公主号游轮上的 2019 年冠状病毒病(COVID-19)病例的无症状比例。
Euro Surveill. 2020 Mar;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.2000180.
3
What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks?
粒度洞察:一种基于废水的机器学习方法用于局部地区新冠肺炎住院预测。
medRxiv. 2025 Jun 26:2025.06.25.25330294. doi: 10.1101/2025.06.25.25330294.
4
Safe, Smart, and Scalable: A Prospective Multicenter Study on Low-Dose CT and CTSS for Emergency Risk Stratification in COVID-19.安全、智能且可扩展:一项关于低剂量CT和CTSS用于COVID-19紧急风险分层的前瞻性多中心研究。
J Clin Med. 2025 Jun 21;14(13):4423. doi: 10.3390/jcm14134423.
5
The collaboration between infectious disease modeling and public health decision-making based on the COVID-19.基于新冠疫情的传染病建模与公共卫生决策之间的合作。
J Saf Sci Resil. 2021 Jun;2(2):69-76. doi: 10.1016/j.jnlssr.2021.06.001. Epub 2021 Jun 12.
6
Extended Analysis of the Hospitalization Cost and Economic Burden of COVID-19 in Romania.罗马尼亚新冠肺炎住院费用及经济负担的深入分析
Healthcare (Basel). 2025 Apr 24;13(9):982. doi: 10.3390/healthcare13090982.
7
COVID-19 and Acute Myocardial Infarction: Exploring Clinical Factors and Treatment Expenditures.新型冠状病毒肺炎与急性心肌梗死:临床因素及治疗费用探究
J Tehran Heart Cent. 2024 Apr;19(2):109-115. doi: 10.18502/jthc.v19i2.16200.
8
Direct medical cost of adult Covid-19 ınpatients and ıts determinants at a university hospital.某大学医院成人新冠住院患者的直接医疗费用及其影响因素
PLoS One. 2025 Apr 7;20(4):e0319762. doi: 10.1371/journal.pone.0319762. eCollection 2025.
9
Modeling the amplification of epidemic spread by individuals exposed to misinformation on social media.模拟社交媒体上接触错误信息的个体对疫情传播的放大作用。
Npj Complex. 2025;2(1):11. doi: 10.1038/s44260-025-00038-y. Epub 2025 Apr 2.
10
Mechanical Ventilator Acquisition Strategy in a Large Private Tertiary Medical Center Using Monte Carlo Simulation.大型私立三级医疗中心使用蒙特卡洛模拟的机械通气机采购策略
Acta Med Philipp. 2025 Feb 28;59(3):57-69. doi: 10.47895/amp.vi0.3892. eCollection 2025.
不同的寨卡病毒疫苗接种策略在预防和缓解寨卡病毒爆发方面的价值是什么?
J Infect Dis. 2019 Aug 9;220(6):920-931. doi: 10.1093/infdis/jiy688.
4
Health care utilization and the cost of posttraumatic acute respiratory distress syndrome care.创伤后急性呼吸窘迫综合征治疗的医疗保健利用和费用。
J Trauma Acute Care Surg. 2018 Jul;85(1):148-154. doi: 10.1097/TA.0000000000001926.
5
Healthcare utilization and costs in ARDS survivors: a 1-year longitudinal national US multicenter study.ARDS 幸存者的医疗保健利用和费用:一项为期 1 年的美国全国多中心纵向研究。
Intensive Care Med. 2017 Jul;43(7):980-991. doi: 10.1007/s00134-017-4827-8. Epub 2017 May 26.
6
The potential economic burden of Zika in the continental United States.寨卡病毒在美国大陆可能造成的经济负担。
PLoS Negl Trop Dis. 2017 Apr 27;11(4):e0005531. doi: 10.1371/journal.pntd.0005531. eCollection 2017 Apr.
7
Clinical Predictors of Hospital Mortality Differ Between Direct and Indirect ARDS.直接型和间接型急性呼吸窘迫综合征(ARDS)患者的医院死亡率临床预测因素有所不同。
Chest. 2017 Apr;151(4):755-763. doi: 10.1016/j.chest.2016.09.004. Epub 2016 Sep 20.
8
One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial.急性呼吸窘迫综合征(ARDS)患者的一年资源利用、成本和生活质量:一项随机对照试验的二次分析。
J Intensive Care. 2016 Aug 11;4:56. doi: 10.1186/s40560-016-0178-8. eCollection 2016.
9
The cost of an Ebola case.一例埃博拉病例的成本。
Pathog Glob Health. 2015 Feb;109(1):4-9. doi: 10.1179/2047773214Y.0000000169. Epub 2015 Jan 11.
10
Modelling during an emergency: the 2009 H1N1 influenza pandemic.紧急情况下的建模:2009 年 H1N1 流感大流行。
Clin Microbiol Infect. 2013 Nov;19(11):1014-22. doi: 10.1111/1469-0691.12284. Epub 2013 Jun 25.